The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study

被引：0
|
作者：
Jinbin Chen
Peiyao Xiong
Man Nie
Yangxun Pan
Juncheng Wang
Dandan Hu
Zhongguo Zhou
Yaojun Zhang
Minshan Chen
Li Xu
机构：
[1] Sun Yat-Sen University Cancer Center,State Key Laboratory of Oncology in South China
[2] Collaborative Innovation Center for Cancer Medicine,Department of Liver Surgery
[3] Sun Yat-Sen University Cancer Center,Department of Medical Oncology
[4] Sun Yat-Sen University Cancer Center,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Hepatocellular carcinoma; Lenvatinib; Local therapy; PD-1/PD-L1 inhibitor; Combination therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2491 / 2500
页数：9
相关论文
共 50 条
  • [21] Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
    Shimozato, Naotaka
    Namisaki, Tadashi
    Okano, Akihiro
    Ohana, Masaya
    Kinoshita, Daisuke
    Kawasaki, Toshihiko
    Aihara, Yosuke
    Nakatani, Toshiya
    Kinoshita, Hiroki
    Ann, Tatsuichi
    Saito, Ko
    Yoshida, Motoyuki
    Yoshiji, Hitoshi
    [J]. ANTICANCER RESEARCH, 2022, 42 (01) : 173 - 183
  • [22] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
    Mara Persano
    Margherita Rimini
    Toshifumi Tada
    Goki Suda
    Shigeo Shimose
    Masatoshi Kudo
    Jaekyung Cheon
    Fabian Finkelmeier
    Ho Yeong Lim
    Lorenza Rimassa
    José Presa
    Gianluca Masi
    Changhoon Yoo
    Sara Lonardi
    Francesco Tovoli
    Takashi Kumada
    Naoya Sakamoto
    Hideki Iwamoto
    Tomoko Aoki
    Hong Jae Chon
    Vera Himmelsbach
    Tiziana Pressiani
    Takumi Kawaguchi
    Margarida Montes
    Caterina Vivaldi
    Caterina Soldà
    Fabio Piscaglia
    Atsushi Hiraoka
    Takuya Sho
    Takashi Niizeki
    Naoshi Nishida
    Christoph Steup
    Massimo Iavarone
    Giovanni Di Costanzo
    Fabio Marra
    Mario Scartozzi
    Emiliano Tamburini
    Giuseppe Cabibbo
    Francesco Giuseppe Foschi
    Marianna Silletta
    Masashi Hirooka
    Kazuya Kariyama
    Joji Tani
    Masanori Atsukawa
    Koichi Takaguchi
    Ei Itobayashi
    Shinya Fukunishi
    Kunihiko Tsuji
    Toru Ishikawa
    Kazuto Tajiri
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5591 - 5602
  • [23] Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China
    Wang, Dong-Xu
    Yang, Xu
    Lin, Jian-Zhen
    Bai, Yi
    Long, Jun-Yu
    Yang, Xiao-Bo
    Seery, Samuel
    Zhao, Hai-Tao
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (30) : 4465 - 4478
  • [24] Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
    Ben Khaled, Najib
    Moeller, Marie
    Jochheim, Leonie S.
    Leyh, Catherine
    Ehmer, Ursula
    Boettcher, Katrin
    Pinter, Matthias
    Balcar, Lorenz
    Scheiner, Bernhard
    Weich, Alexander
    Leicht, Hans Benno
    Zarka, Valentina
    Ye, Liangtao
    Schneider, Julia
    Piseddu, Ignazio
    Oecal, Osman
    Rau, Monika
    Sinner, Friedrich
    Venerito, Marino
    Gairing, Simon Johannes
    Foerster, Friedrich
    Mayerle, Julia
    Toni, Enrico N. De
    Geier, Andreas
    Reiter, Florian P.
    [J]. JHEP REPORTS, 2024, 6 (06)
  • [25] A real-world study of sorafenib and lenvatinib: A retrospective review of multikinase inhibitor therapies for hepatocellular carcinoma in an Australian tertiary treatment center
    Patwala, K.
    Alam, W.
    Ng, S.
    O'Neill, P.
    Mishra, G.
    Bell, S.
    Dev, A.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 97 - 98
  • [26] Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Kimura, Megumi
    Shimazaki, Tomoe
    Maehara, Osamu
    Shigesawa, Taku
    Suzuki, Kazuharu
    Nakamura, Akihisa
    Ohara, Masatsugu
    Umemura, Machiko
    Kawagishi, Naoki
    Natsuizaka, Mitsuteru
    Nakai, Masato
    Morikawa, Kenichi
    Furuya, Ken
    Baba, Masaru
    Yamamoto, Yoshiya
    Kobayashi, Tomoe
    Meguro, Takashi
    Saga, Akiyoshi
    Miyagishima, Takuto
    Yokoo, Hideki
    Kamiyama, Toshiya
    Taketomi, Akinobu
    Sakamoto, Naoya
    [J]. JGH OPEN, 2020, 4 (01): : 54 - 60
  • [27] LENVATINIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD PRACTICE - MULTICENTER ANALYSIS OF PROGNOSTIC FACTORS
    Hiraoka, Atsushi
    Kumada, Takashi
    Atsukawa, Masanori
    Hirooka, Masashi
    Ishikawa, Toru
    Kunihiko, Tsuji
    Takaguchi, Koichi
    Kariyama, Kazuya
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Shibata, Hiroshi
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi, Sr.
    Nagano, Takuya
    Itokawa, Norio
    Hayama, Korenobu
    Imai, Michitaka
    Joko, Kouji
    Koizumi, Yohei
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    [J]. HEPATOLOGY, 2019, 70 : 217A - 218A
  • [28] Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
    Hiraoka, Atsushi
    Kumada, Takashi
    Kariyama, Kazuya
    Takaguchi, Koichi
    Atsukawa, Masanori
    Itobayashi, Ei
    Tsuji, Kunihiko
    Tajiri, Kazuto
    Hirooka, Masashi
    Shimada, Noritomo
    Shibata, Hiroshi
    Ishikawa, Toru
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Itokawa, Norio
    Imai, Michitaka
    Joko, Kouji
    Hiasa, Yoichi
    Michitaka, Kojiro
    [J]. CANCER MEDICINE, 2019, 8 (01): : 137 - 146
  • [29] Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients in the USA
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abby
    Davis, Keith L.
    Iyer, Shrividya
    [J]. FUTURE ONCOLOGY, 2021, 17 (21) : 2759 - 2768
  • [30] Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea
    Goh, Myung Ji
    Oh, Joo Hyun
    Park, Yewan
    Kim, Jihye
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    [J]. LIVER CANCER, 2021, 10 (01) : 52 - 62
12345